Biopharma Strategy Consultant (PhD-entry level position)

We are a consulting firm consisting of passionate scientific minds working with pharma and biotech companies - helping them bring drugs to the market that make meaningful changes to patients’ lives.

You will be working closely with Managing Partners, Senior Consultants and Consultants in an open team environment, primarily by conducting qualitative and quantitative analyses to help shape the final recommendation for our clients. This is usually focused around scientific and clinical data but often includes business, industry and market landscape analyses. In addition, you will contribute in preparing the final presentation material and will gain direct exposure to our clients through involvement from Day 1 in working team as well as executive meetings.

Requirements

• PhD degree in a relevant biomedical or life sciences related field
• Top‑tier quantitative and qualitative analytical skills
• Attentive to details and able to deliver high‑calibre work on time
• Strong communication skills, both spoken and written, in English
• Keen interest in the pharmaceutical, life science and healthcare industries
• Strong knowledge in Python, SQL and/or Excel an advantage
• Willingness to travel internationally and to relocate to Germany

Our Firm’s Values

• Promote, support and value individual, and thus collective, brilliance – this is embodied by the belief that a collective group of strong minds are greater than the sum of the individuals
• Provide an open & empowering work environment that values innovative ideas, social collaboration and continuous individual development, all with a reasonable work‑life balance
• Generating engaging, challenging & impactful consulting work in the biopharma R&D space with the deliverables pivoted around scientific depth leading to unique strategic insights

Contact Information

Please apply via the “Apply now” button. Further questions? Feel free to reach out to careers@scitaris.com.

About us

Our work is focused on various aspects of R&D strategy, science‑driven screens to identify the most suitable drug in‑licensing opportunities to fit every individual client’s capabilities and goals, as well as reviewing scientific and clinical data, experiments, statistical assumptions, and thus power, estimating its probability of success. All this put into context generates key insights for our clients.